Press

IMAX Corporation Reports Third-Quarter 2015 Financial Results
Oct 28, 2015
HIGHLIGHTS
- Revenues of $85.1 million and Adjusted EBITDA of $26.3 million, up approximately 40% and 50% over the third quarter of last year, respectively
- IMAX increases theatre installation outlook for full-year 2015 to approximately 130 new systems
- Company buys back 1 million shares of IMAX stock in the third quarter, at an average price of $34.25
- IMAX Corp. successfully completes IPO of IMAX China, raising net proceeds of $162 million to be reported on IMAX Corp.'s consolidated balance sheet

NEW YORK, Oct. 28, 2015 /PRNewswire/ -- IMAX Corporation (NYSE: IMAX) today reported third quarter 2015 revenues of $85.1 million, adjusted EBITDA as calculated in accordance with the Company's credit facility of $26.3 million, adjusted net income after non-controlling interest of $12.0 million, or $0.17 per diluted share, and reported net income after non-controlling interest of $8.6 million, or $0.12 per diluted share. The Company also reported a third quarter global per-screen average of $220,500.

IMAX Logo.

"In addition to our strong third-quarter financial results, over the last few months we have accomplished several important strategic and financial objectives," said Richard L. Gelfond, CEO of IMAX Corporation. "We successfully listed shares of IMAX China on the Hong Kong Stock Exchange, we bought back 1 million shares of IMAX Corporation's stock at an average price of $34.25 and we have been installing IMAX theatre systems at an accelerated pace around the globe." 

Network Growth Update

The total IMAX® theatre network consisted of 1,008 systems as of September 30, 2015, of which 887 were located in commercial multiplexes. In the quarter, the Company installed 44 theatres, 34 of which were for new theatre locations, and signed contracts for 35 IMAX theatre systems, of which 33 were for new locations and 2 were for upgrades.  As of September 30, 2015, there were 384 theatres in backlog compared to 397 as of December 31, 2014 and 439 as of September 30, 2014.  For a breakdown of theatre system signings, installations, network and backlog by type, please see the tables at the end of this press release.

Gelfond concluded, "We look forward to the upcoming releases of the latest Bond installment, Spectre, the final Hunger Games chapter and, of course, the much-anticipated Star Wars.  We believe the combination of our network growth, heightened levels of demand for The IMAX Experience® and our strong balance sheet will enable us to capitalize on the upcoming fourth quarter film slate as well as the exciting film slates of 2016 and 2017."

Third-Quarter Segment Results

  • Revenue from sales and sales-type leases was $26.6 million in the third quarter of 2015, compared to $6.6 million in the third quarter of 2014, primarily reflecting the installation of 12 full theatre systems under sales and sales-type lease arrangements in the most recent third quarter, compared to the 6 sales-type theatres the Company installed in the prior-year period. In addition, there were 8 upgrades (7 laser and 1 xenon) in existing locations in the third quarter of 2015, compared to no upgrades in the third quarter of 2014.
  • Revenue from joint revenue-sharing arrangements was $19.8 million in the quarter, compared to $15.2 million in the prior-year period.  During the quarter, the Company installed 22 new theatres under joint revenue-sharing arrangements, compared to 14 in the same period in 2014. Of these installations, 8 were for hybrid joint revenue-sharing compared to 5 hybrid joint revenue-sharing installations in the prior year. The Company had 498 theatres operating under joint revenue-sharing arrangements as of September 30, 2015, as compared to 422 joint-venture theatres one year prior.
  • Production and IMAX DMR® (Digital Re-Mastering) revenues were $20.9 million in the third quarter of 2015, compared to $18.4 million in the third quarter of 2014.  Gross box office from DMR titles was $189.8 million in the third quarter of 2015, compared to $169.0 million in the prior-year period.  The average global DMR box office per screen in the third quarter of 2014 was $220,500 compared to $227,900 in the prior-year period.

Conference Call

The Company will host a conference call today at 4:30 PM ET to discuss its third quarter 2015 financial results. To access the call via telephone, interested parties in the US and Canada should dial (800) 524-8850 approximately 5 to 10 minutes before the call begins.  International callers should dial (416) 204-9702. The conference ID for the call is 252835. A replay of the call will be available via webcast on the 'Investor Relations' section of www.imax.com or via telephone by dialing (888) 203-1112 (US and Canada), or (647) 436-0148 (international). The Conference ID for the telephone replay is 252835.

About IMAX Corporation

IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you've never imagined. Top filmmakers and studios are utilizing IMAX theatres to connect with audiences in extraordinary ways, and, as such, IMAX's network is among the most important and successful theatrical distribution platforms for major event films around the globe.

IMAX is headquartered in New York, Toronto and Los Angeles, with offices in London, Tokyo, Shanghai and Beijing.  As of September 30, 2015, there were 1,008 IMAX theatres (887 commercial multiplexes, 19 commercial destinations and 102 institutions) in 66 countries. On Oct. 8, 2015, shares of IMAX China, a subsidiary of IMAX Corp., began trading on the Hong Kong Stock Exchange under the stock code "HK.1970."

IMAX®, IMAX® 3D, IMAX DMR®, Experience It In IMAX®, An IMAX 3D Experience®, The IMAX Experience®, IMAX Is Believing® and IMAX nXos® are trademarks of IMAX Corporation. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).

This press release contains forward looking statements that are based on IMAX management's assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include, but are not limited to, the signing of theater system agreements; conditions, changes and developments in the commercial exhibition industry; the performance of IMAX DMR films; the potential impact of increased competition in the markets within which the Company operates; competitive actions by other companies; the failure to respond to change and advancements in digital technology; risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada; risks related to the Company's growth and operations in China; the Company's largest customer accounting for a significant portion of the Company's revenue and backlog; risks related to new business initiatives; conditions in the in-home and out-of-home entertainment industries; the opportunities (or lack thereof) that may be presented to and pursued by the Company; risks related to the Company's inability to protect the Company's intellectual property; risks related to the Company's implementation of a new enterprise resource planning system; general economic, market or business conditions; the failure to convert theater system backlog into revenue; changes in laws or regulations; risks related to the Company's dependence on a sole supplier for its analog film; risks related to cybersecurity; and other factors, many of which are beyond the control of the Company. These factors, other risks and uncertainties and financial details are discussed in IMAX's most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

 

For additional information please contact:

Investors:

IMAX Corporation, New York

Jessica Kourakos

212-821-0110

jkourakos@imax.com

 

Business Media:

Sloane & Company, New York

Whit Clay

212-446-1864

wclay@sloanepr.com  

 

Media:

IMAX Corporation, New York

Ann Sommerlath

212-821-0155

asommerlath@imax.com

 

Entertainment Media:

Principal Communications Group, Los Angeles

Melissa Zuckerman/Paul Pflug

323-658-1555

melissa@pcommgroup.com

paul@pcommgroup.com

 







Signings and Installations






Sept. 30, 2015









Three Months






Ended Sept. 30,




Theater Signings:

2015


2014





Full new sales and sales-type lease arrangements

11


22





New joint revenue sharing arrangements

22


14




  Total new theaters

33


36













Upgrades of IMAX theater systems

2

(1)

6

(2)



Total Theater Signings

35


42














Three Months






Ended Sept. 30,




Theater Installations:

2015


2014





Full new sales and sales-type lease arrangements

12


6





New joint revenue sharing arrangements

22


14




  Total new theaters

34


20





Upgrades of IMAX theater systems

10

(3)

-




Total Theater Installations

44


20














As of Sept. 30,




Theater Backlog:

2015


2014





New sales and sales-type lease arrangements

160


169





New joint revenue sharing arrangements

204


244




  Total new theaters

364


413













Upgrades of IMAX theater systems

20


26




Total Theaters in Backlog

384

(4)(5)

439

(4)(6)













As of Sept. 30,




Theater Network:

2015


2014




Commercial Multiplex Theaters:








Sales and sales-type lease arrangements

389


329





Joint revenue sharing arrangements

498


422




Total Commercial Multiplex Theaters

887


751












Commercial Destination Theaters

19


19




Institutional Theaters

102


110




Total IMAX Theater Network

1,008


880



























(1)

Includes one signing for the installation of a laser-based digital system and one signing for the installation of a xenon-based digital system under sale and sales-type lease arrangements in existing theater locations.

(2)

Includes one signing for the installation of a laser-based digital system under a sale and sales-type lease arrangement and five signings for the installation of a xenon-based digital system, of which 4 were under joint revenue sharing arrangements and one under a short-term operating lease arrangement in existing theater locations.

(3)

Includes 9 installations of an upgrade to a laser-based digital system (7 under a sale and sales-type lease arrangement, 1 under an operating lease arrangement and 1 under a joint revenue sharing arrangement) and 1 installation of an upgrade to a xenon-based digital system under a sales and sales-type lease arrangement.

(4)

Includes 69 laser theater system configurations (2014 – 69), including upgrades. The Company continues to develop and roll out its laser projection system.

(5)

Includes 20 upgrades to a digital theater system, in existing IMAX theater locations (2 xenon and 18 laser, of which 4 are under joint revenue sharing arrangements).

(6)

Includes 26 upgrades to a digital theater system, in existing IMAX theater locations (3 xenon and 23 laser, of which 4 are under joint revenue sharing arrangements).

 

 

IMAX Greater China Business Metrics Supplement














Three Months ended September 30,


Nine Months Ended September 30,



2015

2014


2015

2014









IMAX Greater China Box Office

$70.4 million

$48.4 million


$245.4 million

$145.6 million


IMAX Greater China Per Screen Avg.

$301,000

$287,200


$1.1 million

$918,200









Greater China Theatre Installations

25

13


43

26


Greater China Backlog

218

247


218

247


Greater China Network:







Commercial Mulitplex

258

176


258

176


Institution

17

22


17

22


Total

275

198


275

198
















Film Slate

In addition to the 37 IMAX DMR films released to the IMAX theater network during the first nine months of 2015, 7 additional IMAX DMR films have been announced so far to be released in the remaining three months of 2015:

  • Crimson Peak: The IMAXExperience (Universal Studios, October 2015);
  • The Martian: An IMAX 3D Experience (Twentieth Century Fox, October 2015);
  • Spectre: The IMAX Experience (Sony Pictures Entertainment, November 2015);
  • The Hunger Games: Mockingjay Part 2: The IMAXExperience (Lionsgate, November 2015); 
  • In the Heart of the Sea: An IMAX 3D Experience (Warner Bros. Pictures, December 2015);
  • Mojin: The Lost Legend: An IMAX3D Experience (aka "The Ghouls")(Wanda Media Co. Ltd., December 2015); and
  • Star Wars: The Force Awakens: An IMAX3D Experience (Walt Disney Studios, December 2015).

To date, the Company has announced the following 15 titles to be released to the IMAX theater network in 2016:

  • The Finest Hours: An IMAX3D Experience (Walt Disney Studios, January 2016);
  • Batman v Superman: Dawn of Justice: An IMAX 3D Experience (Warner Bros. Pictures, March 2016);
  • Flight Crew: An IMAX 3D Experience (Russia-1 Channel, April 2016);
  • The Jungle Book: An IMAX3D Experience (Walt Disney Studios, April 2016);
  • Captain America: Civil War: An IMAX3D Experience (Walt Disney Studios, May 2016);
  • Alice Through the Looking Glass: An IMAX3D Experience (Walt Disney Studios, May 2016);
  • Warcraft: An IMAX3D Experience (Universal Studios, June 2016);
  • Finding Dory: The IMAXExperience (Walt Disney Studios, June 2016);
  • Tarzan: The IMAX Experience (Warner Bros. Pictures, July 2016);
  • Knights of the Roundtable: King Arthur: The IMAX Experience (Warner Bros. Pictures, July 2016);
  • Suicide Squad: The IMAXExperience (Warner Bros. Pictures, August 2016);
  • The Duelist: The IMAX Experience (Non-Stop Production LLC, October 2016);
  • Doctor Strange: An IMAX3D Experience (Walt Disney Studios, November 2016);
  • Fantastic Beasts and Where to Find Them: The IMAX Experience (Warner Bros. Pictures, November 2016); and
  • Rogue One: An IMAX3D Experience (Walt Disney Studios, December 2016).

In addition, in conjunction with Walt Disney Studios, the Company will be releasing an IMAX original production, A Beautiful Planet, on April 29, 2016.

The Company remains in active negotiations with all of the major Hollywood studios for additional films to fill out its short and long-term film slate, and anticipates that a similar number of IMAX DMR films will be released to the IMAX network in 2016 to 44 slated for release in 2015.

 

 


IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars, except per share amounts)

(Unaudited)




Three Months


Nine Months




Ended September 30,


Ended September 30,




2015


2014


2015


2014


Revenues 













Equipment and product sales 

$

33,083


$

11,765


$

72,824


$

37,621


Services 


33,024



33,199



115,698



101,813


Rentals 


16,665



13,646



59,006



42,278


Finance income 


2,329



2,132



6,803



6,372


Other 


-



-



141



-





85,101



60,742



254,472



188,084


Costs and expenses applicable to revenues 













Equipment and product sales  


21,949



6,041



43,010



19,126


Services  


15,899



14,788



50,201



46,318


Rentals 


4,864



4,471



13,856



12,996





42,712



25,300



107,067



78,440


Gross margin 


42,389



35,442



147,405



109,644


Selling, general and administrative expenses  


24,973



23,513



82,348



68,323



(including share-based compensation expense of $4.3 million and $14.9 million for the three and nine months ended September 30 2015, respectively (2014 - expense of $3.4 million and $11.3 million, respectively)) 













Research and development 


2,722



4,560



9,611



11,468


Amortization of intangibles 


429



441



1,302



1,259


Receivable provisions, net of recoveries 


361



26



709



642


Asset impairments 


245



-



245



-


Impairment of investments 


-



-



350



650


Income from operations 


13,659



6,902



52,840



27,302


Interest income 


222



149



727



189


Interest expense 


(463)



(269)



(1,170)



(803)


Income from operations before income taxes 


13,418



6,782



52,397



26,688


Provision for income taxes 


(2,477)



(1,188)



(12,408)



(6,667)


Loss from equity-accounted investments, net of tax 


(427)



(297)



(1,610)



(721)


Income from continuing operations 


10,514



5,297



38,379



19,300


Net income from discontinued operations, net of tax 


-



-



-



355


Net income 

$

10,514


$

5,297


$

38,379


$

19,655


Less: Net income attributable to non-controlling interests 


(1,904)



(439)



(5,028)



(911)


Net income attributable to Common Shareholders 

$

8,610


$

4,858


$

33,351


$

18,744
















Net income per share - basic: 














Net income per share from continuing operations 

$

0.12


$

0.07


$

0.47


$

0.26



Net income per share from discontinued operations 


-



-



-



0.01




$

0.12


$

0.07


$

0.47


$

0.27
















Net income per share - diluted: 














Net income per share from continuing operations 

$

0.12


$

0.07


$

0.46


$

0.26



Net income per share from discontinued operations 


-



-



-



0.01




$

0.12


$

0.07


$

0.46


$

0.27


Weighted average number of shares outstanding (000's): 














Basic 


69,699



68,480



69,582



68,206



Fully Diluted 


70,860



69,602



71,102



69,597
















Additional Disclosure: 














Depreciation and amortization(1)

$

10,467


$

7,992


$

31,191


$

23,937









(1)

Includes $0.3 million and $0.7 million of amortization of deferred financing costs charged to interest expense for the three and nine months ended September 30, 2015, respectively (2014 - $0.1 million and $0.4 million, respectively).

 



IMAX CORPORATION


CONDENSED CONSOLIDATED BALANCE SHEETS


In accordance with United States Generally Accepted Accounting Principles


(in thousands of U.S. dollars)





As at


As at



September 30,


December 31,



2015


2014



(unaudited)




Assets






Cash and cash equivalents

$

117,361


$

106,503

Accounts receivable, net of allowance for doubtful accounts of $1,558 (December 31, 2014 — $947)


87,534



76,051

Financing receivables


113,984



105,700

Inventories


35,562



17,063

Prepaid expenses


7,106



4,946

Film assets


15,460



15,163

Property, plant and equipment


212,967



183,424

Other assets


34,645



23,047

Deferred income taxes


21,458



23,058

Other intangible assets


28,719



27,551

Goodwill


39,027



39,027

Total assets

$

713,823


$

621,533








Liabilities






Bank indebtedness

$

22,278


$

4,710

Accounts payable


18,118



26,145

Accrued and other liabilities


72,519



75,425

Deferred revenue


106,301



88,566

Total liabilities


219,216



194,846








Commitments and contingencies













Non-controlling interests


87,851



43,912








Shareholders' equity






Capital stock, common shares — no par value. Authorized — unlimited number.







69,193,840 — issued and 69,136,609 — outstanding  (December 31, 2014 — 68,988,050 — issued and outstanding)


373,936



344,862

Less: Treasury stock held in trust, 57,231 shares at cost


(2,141)



-

Other equity


43,769



47,319

Accumulated deficit


(2,544)



(6,259)

Accumulated other comprehensive loss


(6,264)



(3,147)

Total shareholders' equity


406,756



382,775

Total liabilities and shareholders' equity

$

713,823


$

621,533

















 

 


IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars)

(Unaudited)



Nine Months



Ended September 30,



2015


2014

Cash provided by (used in):





Operating Activities






Net income

$

38,379


$

19,655


Net income from discontinued operations


-



(355)

Adjustments to reconcile net income to cash from operations:







Depreciation and amortization


31,191



23,937


Write-downs, net of recoveries


2,928



1,753


Change in deferred income taxes


5,097



3,157


Stock and other non-cash compensation


15,204



11,609


Unrealized foreign currency exchange loss


716



847


Loss from equity-accounted investments


2,756



1,073


Gain on non-cash contribution to equity-accounted investees


(1,146)



(352)

Investment in film assets


(12,069)



(8,398)

Changes in other non-cash operating assets and liabilities


(41,256)



18,372

Net cash provided by operating activities from discontinued operations


-



572


Net cash provided by operating activities


41,800



71,870








Investing Activities






Purchase of property, plant and equipment


(38,443)



(24,686)

Investment in joint revenue sharing equipment


(20,969)



(15,908)

Investment in new business ventures


(2,000)



(2,500)

Acquisition of other intangible assets


(3,622)



(1,979)


Net cash used in investing activities


(65,034)



(45,073)








Financing Activities






Issuance of subsidiary shares to a non-controlling interest


40,000



40,491

Share issuance costs from the issuance of subsidiary shares to a non-controlling interest


(2,000)



(3,556)

Exercise of stock options


23,838



3,672

Increase in bank indebtedness


17,568



-

Credit facility amendment fees paid


(1,310)



-

Repurchase of common shares


(34,279)



(2,369)

Treasury stock purchased for settlement of share based compensation


(10,000)



(790)


Net cash provided by financing activities


33,817



37,448








Effects of exchange rate changes on cash


275



(86)








Increase in cash and cash equivalents during the period


10,858



64,159








Cash and cash equivalents, beginning of period


106,503



29,546

Cash and cash equivalents, end of period

$

117,361


$

93,705









 

 


IMAX CORPORATION

SELECTED FINANCIAL DATA

In accordance with United States Generally Accepted Accounting Principles

(in thousands of U.S. dollars)


The Company has seven reportable segments identified by category of product sold or service provided: IMAX systems; theater system maintenance; joint revenue sharing arrangements; film production and IMAX DMR; film distribution; film post-production; and other. The IMAX systems segment includes the design, manufacture, sale or lease of IMAX theater projection system equipment. The theater system maintenance segment includes the maintenance of IMAX theater projection system equipment in the IMAX theater network. The joint revenue sharing arrangements segment includes the provision of IMAX theater projection system equipment to an exhibitor in exchange for a share of the box-office and concession revenues. The film production and IMAX DMR segment includes the production of films and the performance of film re-mastering services. The film distribution segment includes the distribution of films for which the Company has distribution rights. The film post-production segment provides film post-production and film print services. The other segment includes certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items.





Three Months Ended September 30,


Nine Months Ended September 30,




2015


2014


2015


2014

Revenue 












IMAX Theater Systems 













IMAX Systems 














Sales and sales-type leases 

$

26,635


$

6,644


$

53,924


$

25,629



Ongoing rent, fees, and finance income 


3,518



3,501



10,708



10,272



Other 


3,221



3,165



11,320



8,407





33,374



13,310



75,952



44,308


Theater System Maintenance 


9,337



8,516



27,345



25,384


Joint Revenue Sharing Arrangements 


19,797



15,238



67,259



45,457















Film 













Production and IMAX DMR 


20,865



18,350



75,144



57,585


Film distribution and post-production 


1,728



5,328



8,772



15,350





22,593



23,678



83,916



72,935

Total 

$

85,101


$

60,742


$

254,472


$

188,084















Gross margin 












IMAX Theater Systems 













IMAX systems(1)














Sales and sales-type leases 

$

9,775


$

4,246


$

24,720


$

14,161



Ongoing rent, fees, and finance income 


3,334



3,352



10,111



9,799



Other 


(267)



(218)



(421)



(202)





12,842



7,380



34,410



23,758


Theater System Maintenance 


3,521



3,208



9,891



8,990


Joint Revenue Sharing Arrangements(1)


12,130



9,382



46,816



30,043















Film 













Production and IMAX DMR(1)


13,929



13,469



55,642



43,177


Film distribution and post-production(1)


(33)



2,003



646



3,676





13,896



15,472



56,288



46,853

Total 

$

42,389


$

35,442


$

147,405


$

109,644













(1)

IMAX systems include marketing and commission costs of $0.9 million and $1.8 million for the three and nine months ended September 30, 2015, respectively (2014 — $0.3 million and $1.2 million, respectively). Joint revenue sharing arrangements segment margins include advertising, marketing and commission costs of $1.3 million and $2.7 million for the three and nine months ended September 30, 2015, respectively (2014 — $0.9 million and $2.1 million, respectively). Production and DMR segment margins include marketing costs of $3.4 million and $8.3 million for the three and nine months ended September 30, 2015, respectively (2014 — $2.1 million and $5.3 million, respectively). Distribution segment margins include marketing cost recovery of less than $0.1 million and cost recovery of $0.1 million for the three and nine months ended September 30, 2015, respectively (2014 — expense of $0.3 million and expense of $0.7 million, respectively).

 

 

 



IMAX CORPORATION

OTHER INFORMATION

(in thousands of U.S. dollars)


Non-GAAP Financial Measures:


In this release, the Company presents adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share as supplemental measures of performance of the Company, which are not recognized under U.S. GAAP. The Company presents adjusted net income and adjusted net income per diluted share because it believes that they are important supplemental measures of its comparable controllable operating performance and it wants to ensure that its investors fully understand the impact of its stock-based compensation (net of any related tax impact) on net income. In addition, the Company presents adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share because it believes that they are important supplemental measures of its comparable financial results and could potentially distort the analysis of trends in business performance and it wants to ensure that its investors fully understand the impact of net income attributable to non-controlling interests and its stock-based compensation (net of any related tax impact) in determining net income attributable to common shareholders. Management uses these measures to review operating performance on a comparable basis from period to period. However, these non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share should be considered in addition to, and not as a substitute for, net income and net income attributable to common shareholders and other measures of financial performance reported in accordance with U.S. GAAP.


The Credit Facility provides that the Company will be required at all times to satisfy a Minimum Liquidity Test (as defined in the Credit Agreement) of at least $50.0 million. The Company will also be required to maintain minimum EBITDA (as defined in the Credit Agreement) of $90.0 million until December 30, 2015, which requirement increases to $100.0 million on December 31, 2015. The Company must also maintain a Maximum Total Leverage Ratio (as defined in the Credit Agreement) of 2.5:1.0 until December 30, 2015, which requirement decreases to (i) 2.25:1.0 on December 31, 2015; (ii) 2.0:1.0 on December 31, 2016; and (iii) 1.75:1.0 on December 31, 2017. The ratio of total debt to EBITDA was 0.16:1 as at September 30, 2015, where Total Debt (as defined in the Credit Agreement) is the sum of all obligations evidenced by notes, bonds, debentures or similar instruments and was $22.3 million. EBITDA is calculated as follows:




For the


For the 



3 months ended


12 months ended 


September 30, 2015


September 30, 2015(1)

(In thousands of U.S Dollars) 






Net income 

$

10,514


$

60,893

Add (subtract):  







Loss from equity accounted investments 


427



1,960


Provision for income taxes 


2,477



20,207


Interest expense, net of interest income 


241



348


Depreciation and amortization, including film asset amortization 


10,200



40,215


Write-downs net of recoveries including asset impairments and receivable provisions 


1,471



6,469


Stock and other non-cash compensation 


4,343



19,062


EBITDA attributable to non-controlling interests(2)


(3,399)



(11,031)



$

26,274


$

138,123









(1)

Ratio of funded debt calculated using twelve months ended EBITDA.

(2)

The EBITDA calculation specified for purposes of the minimum EBITDA covenant excludes the reduction in EBITDA from the Company's non-controlling interests.

 

 

 


IMAX CORPORATION

OTHER INFORMATION

(in thousands of U.S. dollars)


Adjusted Net Income and Adjusted Diluted Per Share Calculations – Quarter Ended September 30, 2015 vs. 2014:


The Company reported net income of $10.5 million or $0.15 per basic share and $0.14 per diluted share for the third quarter of 2015, as compared to $5.3 million or $0.08 per basic and diluted share for the third quarter of 2014. Adjusted net income, which consists of net income excluding the impact of stock-based compensation and the related tax impact, was $13.9 million or $0.19 per diluted share for the third quarter of 2015 as compared to adjusted net income of $8.3 million or $0.12 per diluted share for the third quarter of 2014. Adjusted net income attributable to common shareholders, which consists of net income attributable to common shareholders excluding the impact of stock-based compensation and the related tax impact, was $12.0 million or $0.17 per diluted share for the third quarter of 2015 as compared to adjusted net income attributable to common shareholders of $7.8 million or $0.11 per diluted share for the third quarter of 2014. A reconciliation of net income and net income attributable to common shareholders, the most directly comparable U.S. GAAP measures, to adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in the table below:




Three Months



Three Months




Ended September 30, 2015



Ended September 30, 2014




Net Income


Diluted EPS



Net Income


Diluted EPS


Reported net income

$

10,514


$

0.14

(1)


$

5,297


$

0.08

(1)

Adjustments:















Stock-based compensation


4,252



0.06




3,425



0.05



Tax impact on items listed above


(901)



(0.01)




(464)



(0.01)


Adjusted net income


13,865



0.19

(1)



8,258



0.12

(1)


Net income attributable to non-controlling interests


(1,904)



(0.02)




(439)



(0.01)


Adjusted net income attributable to common shareholders

$

11,961


$

0.17

(1)


$

7,819


$

0.11

(1)
















Weighted average diluted shares outstanding





70,860







69,602


























(1)

Includes impact of $0.3 million (2014 - $0.1 million) of accretion charges associated with redeemable Class C shares of IMAX China.

 

 

Adjusted Net Income and Adjusted Diluted Per Share Calculations – Nine Months Ended September 30, 2015 vs. 2014:


The Company reported net income of $38.4 million or $0.54 per basic share and $0.53 per diluted share for the nine months ended September 30, 2015, as compared to $19.7 million or $0.28 per basic and diluted share for the nine months ended September 30, 2014. Adjusted net income, which consists of net income excluding the impact of stock-based compensation and the related tax impact, was $50.7 million or $0.70 per diluted share for the nine months ended September 30, 2015 as compared to adjusted net income of $29.2 million or $0.41 per diluted share for the nine months ended September 30, 2014.  Adjusted net income attributable to common shareholders, which consists of net income attributable to common shareholders excluding stock-based compensation expense and the related tax impact, was $45.7 million, or $0.63 per diluted share, in the nine months ended September 30, 2015, as compared to adjusted net income attributable to common shareholders of $28.3 million, or $0.40 per diluted share, for the nine months ended September 30, 2014. A reconciliation of net income attributable to common shareholders, the most directly comparable U.S. GAAP measure, to adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in the table below:




Nine Months



Nine Months




Ended September 30, 2015



Ended September 30, 2014




Net Income


Diluted EPS



Net Income


Diluted EPS


Reported net income attributable to Common Shareholders

$

38,379


$

0.53

(1)


$

19,655


$

0.28

(1)

Add:















Stock-based compensation


14,931



0.21




11,328



0.16



Tax expense on items listed above


(2,603)



(0.04)




(1,807)



(0.03)


Adjusted net income 


50,707



0.70

(1)



29,176



0.41

(1)


Net income attributable to non-controlling interests


(5,028)



(0.07)




(911)



(0.01)


Adjusted net income attributable to Common Shareholders

$

45,679


$

0.63

(1)


$

28,265


$

0.40

(1)
















Weighted average diluted shares outstanding





71,102







69,597


























(1)

Includes impact of $0.7 million (2014 - $0.3 million) of accretion charges associated with redeemable Class C shares of IMAX China.

 

 

Free Cash Flow:


Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the consolidated statements of cash flows). Cash provided by operating activities consist of net income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company's after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. A reconciliation of cash provided by operating activities to free cash flow is presented in the table below:




For the



Nine Months Ended


September 30, 2015

(In thousands of U.S. Dollars)



Net cash provided by operating activities                                                                         

$

41,800

Net cash used in investing activities


(65,034)

Free cash flow

$

(23,234)

 

Logo - http://photos.prnewswire.com/prnh/20111107/MM01969LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/imax-corporation-reports-third-quarter-2015-financial-results-300168111.html

SOURCE IMAX Corporation